KNOBELMAN DEBORAH
SEC insider (Form 3/4/5 filer). CIK 0001931509. President & Interim CEO at Kronos Bio, Inc. (KRON). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 20, 2025. Located in CAMBRIDGE, MA.
Companies KNOBELMAN DEBORAH has filed insider reports for
- Kronos Bio, Inc. (KRON): Officer, President & Interim CEO
KNOBELMAN DEBORAH
CIK: 0001931509
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KRON
Kronos Bio, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 20, 2025KRON
Kronos Bio, Inc.
Tender OfferDirect139.4K shares at avg. $0.57$79K - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
246.4K shares- - Jun 5, 2025KRON
Kronos Bio, Inc.
SaleDirect24.8K shares at avg. $0.87$22K
1-3 of 3 transactions